• Banasmita Kalita GIPS, AZARA, GUWAHATI 17
  • Kritika Saikia
  • Bhupen Kalita


Objectives: The objective of the present work is to develop and characterize metronidazole microsphere-loaded bioadhesive vaginal gel to ensure
longer residence time at the infection site, providing a favorable release profile for the drug.
Methods: Microsphere was prepared by solvent evaporation method in various ratios of metronidazole to poly-ε-caprolactone (PCL). Physicochemical
evaluation of microspheres includes determination of solubility in simulated vaginal fluid, partition coefficient (n-octanol/citrate phosphate
buffer pH 4.5), particle size distribution, entrapment efficiency, X-ray diffraction, and surface morphology by scanning electron microscopy (SEM).
Drug excipient compatibility was established by Fourier transform infrared and differential scanning calorimetry studies. Bioadhesive gel was
prepared using Carbopol 934P and HPMC K4M in various concentrations, and methyl paraben was used as a preservative. The pH was adjusted
with triethanolamine which resulted in a translucent gel. The optimized metronidazole microsphere formulation was dispersed into the gel base.
Microspheres in gel formulations were evaluated for pH, viscosity, spreadability, drug content, and gelling strength. Ex vivo mucoadhesive strength of
the gel was determined on goat vaginal mucosa. In vitro drug release study was performed using cellophane membrane.
Results: The optimized batch of microsphere F4 (drug-polymer ratio 1:4) showed entrapment efficiency of 72.62±3.66%, solubility of 1.5 mg/ml, and
partition coefficient of 0.12. Particle size of all the formulations was observed below 100 μm. Regular and spherical particles were observed in the
SEM photomicrographs. The optimized gel formulation G5 (Carbopol and HPMC at 1: 0.25 ratio) showed viscosity of 7538 cps at 100 RPM, gel strength
recorded as 35 secobds for a 1000.00 mg load, and spreadability of 4.6 G5 showed 82.4% drug release at 10.0 hrs and mucoadhesive
strength of 6.5±1.2 g.
Conclusion: The study results suggest that metronidazole-loaded PCL microsphere in mucoadhesive gel would provide a mean for sustained
treatment of vaginal infections.
Keywords: Microsphere, Metronidazole, Bioadhesive vaginal gel.

Author Biography

Banasmita Kalita, GIPS, AZARA, GUWAHATI 17
m.pharm, department of pharmaceutics,GIPS, Azara, Ghy 17


1. Chien YW. Vaginal Drug Delivery and Delivery System, Novel Drug Delivery Systems. New York: Marcel Dekker Inc; 1992. p. 529-40.
2. Jones DS, Woolfson AD, Brown AF, O’Neill MJ. Mucoadhesive syringeable drug delivery systems for controlled application of metronidazole to periodontal pocket: In vitro release kinetics, syringeability, mechanical and mucoadhesive properties. J Control Release 1997;49(1):71-9.
3. Karthikeyan K, Durgadevi R, Saravanan K, Shivsankar K, Usha S, Saravanan M. Formulation of bioadhesive carbomer gel incorporating drug-loaded gelatin microspheres for periodontal therapy. Trop J Pharm Res 2012;11(3):335-43.
4. Tiwari G. Biodegradable microspheres for controlled delivery of metronidazole in the treatment of periodontal diseases: Formulation consideration. Int J Pharm Bio Sci 2010;1(2):1-13.
5. Sanap GS, Mohanta GS. Solid lipid nanoparticles - based hydrogel formulation for topical delivery of miconazole nitrate. Int J Pharm Bio Sci 2013;4(2):21-33.
6. Kataria S, Middha A, Sandhu P, Bilandi A, Kapoor A. Microsphere: A review. Int J Res Pharm Chem 2011;1(4):1184-98.
7. Reddy KV, Patra PK, Divakar K, Reddy BV. Formulation and in vitro studies of carvedilol microspheres with its characterization. Int J Pharm Pharm Sci 2014;6(4):329-32.
8. Golomb G, Friedman M, Soskolne A, Stabholz A, Sela MN. Sustained release device containing metronidazole for periodontal use. J Dent Res 1984;63:1149-53.
9. Mukerjee A, Sinha VR, Pruthi V. Preparation and characterization of poly-ε-caprolactone particles for controlled insulin delivery. J Biomed Pharm Eng 2007;1(1):40-4.
10. Kim SY, Lee YM, Baik DJ, Kang JS. Toxic characteristics of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) nanospheres; in vitro and in vivo studies in the normal mice. Biomaterials 2003;24(1):55-63.
11. Patel PV, Daslaniya DJ, Patel UL, Shah R. Formulation and evaluation of bioadhesive gel incorporated amoxicillin trihydrate loaded microspheres for periodontal therapy. Int J Pharm Innov 2013;3(3):98-109.
12. Sharma YR. Elementary Organic Spectroscopy, Principles and Chemical Applications. Vol. 4. New Delhi: Rajendra Ravindra Printers Pvt., Ltd.; 2011. p. 64-113.
13. Parmar VJ, Lumbhani AN. Formulation and development of thermos-reversible mucoadhesive intranasal in situ hydrogel by using a combination of polymers. Bull Pharm Res 2012;2(3):167-74.
14. Wu XG, Li G, Gao YL. Optimization of the preparation of nalmefene-loaded sustained-release microspheres using central composite design.
Chem Pharm Bull 2006;54(7):977-81.
15. Reddy JR, Gnanaprakash K, Badarinath AV, Chetty CM. Formulation and evaluation of microparticles of metronidazole J Pharm Sci Res 2009;1(10):131-6.
16. Chowdary KP, Annapurna A. Influence of core and method of preparation on microencapsulation efficiency and drug release and permeability of ethyl cellulose microcapsules. East Pharm 1992;9:129-31.
17. Chadawar V, Shaji J. Microsponge delivery system. Curr Drug Deliv 2007;4(2):123-9.
18. Hani U, Bhat RS, Shivakumar HG. Formulation design and evaluation of metronidazole microspheres in a bioadhesive gel for local therapy of vaginal candidiasis. Lat Am J Pharm 2011;30(1):161-7.
19. Adimoolam S, Bhai TH, Vinod DM, Bharat LT, Battu BL. Formulation and evaluation of mucoadhesive microspheres of venlafaxin HCL. Int Res J Pharm 2011;2(4):194-9.
20. Galgatte UC, Chaudhari PD. Preformulation study of poloxamer 407 Gels: Effect of additives. Int J Pharm Pharm Sci 2014;1(1):130-3.
21. Chatterjee A, Bhowmik BB, Thakur YS. Formulation, in vitro and in vivo pharmacokinetics of anti-HIV vaginal bioadhesive Gel. J Young Pharm 2011;3(2):83-9.
22. Deveda P, Jain A, Vyas N, Khambete H, Jain S. Gellified emulsion for sustain deliver of itrakonazole for topical fungal diseases. Int J Pharm Pharm Sci 2010;2(1):104-12.
23. Yellanki SK, Narella NK, Goranti S, Deb SK. Development of metronidazole intravaginal gel for the treatment of bacterial vaginosis, effect of mucoadhesive natural polymers on the release of metronidazole. Int J Pharm Res Dev 2010;2(3):1-6.
24. Karavana SY, Seda R, Zeynep S, Esra B. A new in-situ gel formulation of itraconazole for vaginal administration. Res J Pharmacol Pharm 2012;3(4):417-26.
25. Kumar J, Muralidharan S, Parasuraman S. In vitro and in vivo evaluation of microspheres loaded topical gel delivery system of ketoconazole in male rats against Candida glabrata. J Pharm Sci Res 2014;6(11):376-81.
26. Mundhey DA, Morris PS, Lohiya GK, Avari JG. Formulation and evaluation of mucoadhesive vaginal gel containing novel combination of metronidazole and miconazole nitrate for the treatment of vaginitis. World J Pharm Sci 2015;4:910-8.
751 Views | 1051 Downloads
How to Cite
Kalita, B., K. Saikia, and B. Kalita. “FORMULATION AND EVALUATION OF METRONIDAZOLE MICROSPHERES-LOADED BIOADHESIVE VAGINAL GEL”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, no. 3, Mar. 2017, pp. 418-24, doi:10.22159/ajpcr.2017.v10i3.16417.
Original Article(s)